[ad_1]
Live 2018
A Multi-Institutional Consortium Will Offer Improved Personalized Treatments to Patients With Melanoma and Leukemia in Quebec
Leading Researchers, Cancer Centers and Montreal Hospitals Partner with Generate new advances in personalized and precision medicine with the goal of improving treatments for 18,000 patients treated each year with cancer.
The Montreal Cancer Multi-Institutional Consortium will bring together researchers and clinicians from the Faculty of Medicine at McGill University. Research Center (CRCG), McGill University Health Center (MUHC) and its Research Institute, Jewish General Hospital (JGH), University Hospital of Montreal (CHUM), Maisonneuve-Rosemont Hospital Research Center, Institute for Immunology and Cancer Research (IRIC) and Génome Québec Innovation Center
For the Terry Fox Ric Institute research, the launch of this consortium marks a new step forward in the acceleration of medicine precision for all Canadians. This is the second pilot project that the Institute created as part of its strategy for a pan-Canadian network of related cancer centers
The Montreal Pilot Project members will develop immunotherapy, a new cancer treatment strategy. to fight cancer and has recently shown impressive results for some patients
Cancer patients like Stan Czebruk will benefit from new approaches to immunotherapy piloted by the Montreal Cancer Consortium.
Stan Czebruk is a patient whose life has changed through immunotherapy.
"It was in 2009. I was hiking in Scotland, when my wife called me and announced that I had cancer.It was a melanoma to my left ear that later spread to my lungs and my brain, "says the 60-year-old Montrealer, who is being treated at the McGill University Health Center, after two craniotomies and a battery of treatments, he is now in remission and will undergo his last immunotherapy treatment in early August
The Montreal Cancer Consortium will focus first on the immunotherapy treatments for melanoma and acute leukemia and will use knowledge and knowledge "It has been a long journey, but I have confidence in the health care system and hope that more research will be done and more treatments will be found," says Czebruk, a graduate. from Concordia University with a bachelor's degree t in commerce in the 80s, has since decided to return to his first pbadion by starting a double in geography at his old university in September.
been done in the research on melanoma in Quebec; There is now an urgent need to develop a network to recruit patients and offer them new therapeutic options within a center of expertise. "This is the goal of this consortium of experts to stimulate cancer research and care," said Dr. Catalin Mihalcioiu, CCM co-investigator, MUHC medical oncologist, researcher at the Research Program on Cancer Research and Cancer Care. cancer of the RI-MUHC. Assistant Professor of Medicine at McGill University
"Melanoma is a type of cancer that can be easily overlooked, especially in the elderly or youth who do not pay attention to their health," adds Dr. Mihalcioiu, who has been treating Mr. Czebruk since 2013.
Working together, MCC researchers will also aim to better understand how different aspects of the immune system relate to acute leukemia and why the therapy works for some patients but not for others. They hope to identify new biomarkers and new targets that will respond to immunotherapy treatments.
Ian Watson (CRCG) and John Stagg (CRCHUM) will be co-principal investigators for the new pilot project.
"In total, the Montreal Cancer Consortium will harness the power of data from more than 18,000 patients each year and over 50," said Dr. Ian Watson, Canada Research Chair in Functional Genomics of Melanoma. Assistant Professor, Department of Biochemistry, McGil, member of the Goodman Cancer Research Center and co-principal investigator of the MCC project
MCC will receive $ 6.5 million over the next two years from several organizations supporting l & # 39; initiative. As a catalyst for the project, the IRTF provides $ 2 million and Oncopole, Genome Quebec, the Goodman Cancer Research Center and the Montreal Cancer Institute are among the other co-financers
B-roll, photos, information document
http://tfri.ca/en/NewsEvents/news/news-releases-detail/2018/06/25/the-terry- fox-research-institute-and-montreal-research-partners-train-consortium-to-provide-more-personalized-treatments-for-cancer-patients-in-a-cca
Source link
